The relationship between subcortical tau pathology and Alzheimer's disease - PubMed (original) (raw)

Review

The relationship between subcortical tau pathology and Alzheimer's disease

Johannes Attems et al. Biochem Soc Trans. 2012 Aug.

Abstract

The stepwise progression of tau pathology [NFTs (neurofibrillary tangles) and NTs (neuropil threads)] in AD (Alzheimer's disease) is generally assumed to begin in the transentorhinal region (entorhinal stage) from which it progresses to the hippocampus (limbic stage) and to neocortical regions (neocortical stage). This stepwise progression is reflected in the NFT Braak stages. However, it has been shown recently that tau pathology is frequently seen in subcortical nuclei, in particular the LC (locus coeruleus) in over 90% of individuals under 30 years of age, suggesting that AD-associated tau pathology begins in the LC and not in the transentorhinal region. On the other hand, only minimal amounts of tau pathology are seen in the LC in cases with considerable entorhinal tau pathology, while the severity of tau pathology in the LC significantly increases with increasing NFT Braak stages. These findings suggest that the LC becomes increasingly involved during AD progression rather than representing the site initially affected. Further studies are warranted to answer the question of whether tau pathology in the LC of young individuals is associated with AD or whether it rather reflects non-specific neuronal damage.

PubMed Disclaimer

Cited by

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.
Chalermpalanupap T, Kinkead B, Hu WT, Kummer MP, Hammerschmidt T, Heneka MT, Weinshenker D, Levey AI. Chalermpalanupap T, et al. Alzheimers Res Ther. 2013 Apr 29;5(2):21. doi: 10.1186/alzrt175. eCollection 2013. Alzheimers Res Ther. 2013. PMID: 23634965 Free PMC article. Review.
Primary Age-Related Tauopathy in Human Subcortical Nuclei.
Zhu K, Wang X, Sun B, Wu J, Lu H, Zhang X, Liang H, Zhang D, Liu C. Zhu K, et al. Front Neurosci. 2019 May 29;13:529. doi: 10.3389/fnins.2019.00529. eCollection 2019. Front Neurosci. 2019. PMID: 31191227 Free PMC article.
MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.
Llorens F, Thüne K, Andrés-Benito P, Tahir W, Ansoleaga B, Hernández-Ortega K, Martí E, Zerr I, Ferrer I. Llorens F, et al. J Mol Neurosci. 2017 Oct;63(2):206-215. doi: 10.1007/s12031-017-0971-4. Epub 2017 Sep 5. J Mol Neurosci. 2017. PMID: 28871468
Functional near-infrared spectroscopy and vagus somatosensory evoked potentials add to the power of established parameters such as poor cognitive performance, dsyosmia and APOe genotype to predict cognitive decline over 8 years in the elderly.
Herrmann MJ, Wuttke A, Breuninger L, Eff J, Ettlinger S, Fischer M, Götzelmann A, Gram A, Pomper LD, Schneider E, Schwitalla L, Siminski N, Spielmann F, Weinmann E, Weyel V, Zeller JBM, Lauer M, Deckert J, Polak T. Herrmann MJ, et al. J Neural Transm (Vienna). 2024 Nov 13. doi: 10.1007/s00702-024-02859-y. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 39535568
Asymmetric amyloid deposition in preclinical Alzheimer's disease: A PET study.
Kjeldsen PL, Parbo P, Hansen KV, Aanerud JFA, Ismail R, Nissen PH, Dalby RB, Damholdt MF, Borghammer P, Brooks DJ. Kjeldsen PL, et al. Aging Brain. 2022 Aug 26;2:100048. doi: 10.1016/j.nbas.2022.100048. eCollection 2022. Aging Brain. 2022. PMID: 36908895 Free PMC article.

The relationship between subcortical tau pathology and Alzheimer's disease - PubMed (original) (raw)